Suppr超能文献

K252a是磷酸化酶激酶的一种强效且选择性抑制剂。

K252a is a potent and selective inhibitor of phosphorylase kinase.

作者信息

Elliott L H, Wilkinson S E, Sedgwick A D, Hill C H, Lawton G, Davis P D, Nixon J S

机构信息

Roche Products Limited Welwyn Garden City, Herts, UK.

出版信息

Biochem Biophys Res Commun. 1990 Aug 31;171(1):148-54. doi: 10.1016/0006-291x(90)91369-4.

Abstract

The inhibition of phosphorylase kinase by a number of protein kinase inhibitors was examined. Both K252a and staurosporine are potent inhibitors of phosphorylase kinase with IC50 values of 1.7 nM and 0.5 nM respectively. K252a shows a 300-fold selectivity for this enzyme over protein kinase C whereas staurosporine shows only a 20-fold selectivity for phosphorylase kinase. In contrast, the Roche bis-indolyl maleimides inhibit phosphorylase kinase with IC50 values of approximately 1 microM and are highly selective for protein kinase C.

摘要

研究了多种蛋白激酶抑制剂对磷酸化酶激酶的抑制作用。K252a和星形孢菌素都是磷酸化酶激酶的有效抑制剂,IC50值分别为1.7 nM和0.5 nM。K252a对该酶的选择性比对蛋白激酶C高300倍,而星形孢菌素对磷酸化酶激酶的选择性仅为20倍。相比之下,罗氏双吲哚马来酰亚胺以约1 microM的IC50值抑制磷酸化酶激酶,并且对蛋白激酶C具有高度选择性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验